CVS's most recent trend suggests a bullish bias. One trading opportunity on CVS is a Bull Put Spread using a strike $63.00 short put and a strike $58.00 long put offers a potential 9.17% return on risk over the next 6 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $63.00 by expiration. The full premium credit of $0.42 would be kept by the premium seller. The risk of $4.58 would be incurred if the stock dropped below the $58.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for CVS is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for CVS is bullish.
The RSI indicator is at 58.83 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for CVS
Trends positive in cost of health care, but 'dark clouds' brood
Thu, 12 Sep 2019 21:10:40 +0000
Panelists at our Trends & Innovations in Health Benefits event point to improvements in controlling the cost of care, but challenges on the horizon.
Google Photos and CVS Pharmacy Team Up to Offer Same-Day Printing at More Than 7,400 Locations Nationwide
Thu, 12 Sep 2019 17:32:00 +0000
WOONSOCKET, R.I., Sept. 12, 2019 /PRNewswire/ — CVS Pharmacy, the retail division of CVS Health (CVS), today announced a collaboration with Google Photos on their new same-day, print-to-store experience. Consumers can now order high-quality 4×6 prints directly from Google Photos for same-day pick up at more than 7,400 CVS Pharmacy locations nationwide. The printing service for CVS Pharmacy, powered by Kodak Moments' vast global retail network and enhanced software technology, begins rolling out across the country today and will be broadly available by this October.
Health-Care Stocks Are Worth a Look Despite Worry Over Price Regulation, Analyst Says
Thu, 12 Sep 2019 16:45:00 +0000
The sector has lagged behind the broader market, partly because of concern that the government could act to rein in drug prices.
Here's What We Know About How Drugs Are Priced — And What We Don't
Thu, 12 Sep 2019 14:06:26 +0000
Pharmaceutical companies and middlemen known as pharmacy benefit managers are generally at odds in a battle over drug prices. So, who is actually responsible for high prescription prices?
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NGHC, GTT, ABMD and CVS
Thu, 12 Sep 2019 13:24:10 +0000
NEW YORK, Sept. 12, 2019 — The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
Also on Market Tamer…
Follow Us on Facebook